During the past two years CLB has received grant support from Repligen, Janssen, Bristol-Myers Squibb, and the National Institute for Mental Health; and has served as a consultant to Bristol-Myers Squibb, Dainippon, Forest Labs, Pfizer, Repligen, and Sanofi-Aventis.
Anticonvulsants in bipolar disorders: current research and practice and future directions
Version of Record online: 1 JUN 2009
© 2009 John Wiley & Sons A/S
Special Issue: Lithium and the Modern Management of Bipolar Disorder
Volume 11, Issue Supplement s2, pages 20–33, June 2009
How to Cite
Bowden, C. L. (2009), Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disorders, 11: 20–33. doi: 10.1111/j.1399-5618.2009.00708.x
- Issue online: 1 JUN 2009
- Version of Record online: 1 JUN 2009
- Received 9 December 2008, revised and accepted for publication 9 April 2009
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.